Big Move For Phio Pharmaceuticals Corp.
Mon, Jan 13, 2025 at 07:19 PM
Phio Pharmaceuticals Corp. (PHIO:NASDAQ) shot up at $6.6, representing a gain of 290.5%. On Mon, Jan 13, 2025, PHIO:NASDAQ hit a New 2-Week High of $6.6. The stock got featured on our News Catalysts scanner on Mon, Jan 13, 2025 at 01:12 PM in the 'BIOTECH' category. From Mon, Dec 30, 2024, the stock recorded 37.50% Up Days and 44.44% Green Days
The stock spiked on Mon, Jan 13, 2025 at $9.79 with a volume of 280M+.
About Phio Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
Top 10 Gainers:
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 290.53%
- Smart for Life Inc. (SMFL:NASDAQ), 260%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 135.26%
- Kairos Pharma Ltd. (KAPA:NYSEMKT), 119.59%
- Azitra Inc (AZTR:NYSEMKT), 59.72%
- Agape ATP Corporation (ATPC:NASDAQ), 56.35%
- Avinger, Inc. (AVGR:NASDAQ), 42.62%
- Neuronetics, Inc. (STIM:NASDAQ), 36.84%
- Sage Therapeutics, Inc. (SAGE:NASDAQ), 35.14%
- Intra-Cellular Therapies, Inc. (ITCI:NASDAQ), 34.07%